ClinicalTrials.govpublic full text
PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate Cancer
prostate cancer, bombesin, gastrin-releasing peptide, prostatic neoplasms, genital diseases, male, genital neoplasms, male, neoplasms, neoplasms by site, urogenital neoplasms, gastrointestinal agents, molecular mechanisms of pharmacological action, neurotransmitter agents
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 908254
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.